CervoMedCRVO
那斯達克 · USD
8.83
+0.58
(+7.03%)
收盤 08/02 03:59 (UTC+8)
盤後
8.55
8.55
(-3.50%)
08/02 03:59 (UTC+8)
CervoMedCRVO
8.83
+0.58
(+7.03%)
財務數據
損益表
- -
- 0.01
- -
- 0.02
- 0.02
- 0.02
- 0.03
- 0.02
- 0.02
- 0.02
- -
- -
- -
- -
- -46.48
- -5.78
- 40.14
- -41.02
- 11.44
- -11.33
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 1,917 | 2,162 | 1,940 | 3,289 | 2,347 | 2,491 | 1,526 | - | 1,408 | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,917 | 2,162 | 1,940 | 3,289 | 2,347 | 2,491 | 1,526 | - | 1,408 | - |
營業費用 | - | - | - | 6,284 | - | 4,971 | 4,201 | 2,292 | 2,834 | 13,435 |
研發費用 | 4,838 | 7,087 | 5,125 | 3,772 | 2,814 | 2,855 | 1,791 | 72 | 1,833 | 6,281 |
推銷及管理費用 | 2,383 | 2,316 | 2,211 | 2,512 | 2,128 | 2,116 | 2,410 | 2,220 | 1,001 | 7,154 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -5,303 | -7,241 | -5,396 | -2,995 | -2,595 | -2,480 | -2,675 | -2,293 | -1,426 | -13,435 |
其他收入及費用 | 409 | 535 | 643 | 678 | 81 | 118 | 4,825 | 179 | 892 | 2,120 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -4,894 | -6,706 | -4,754 | -2,317 | -2,514 | -2,362 | 2,150 | -2,113 | -534 | -11,316 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -4,894 | -6,706 | -4,754 | -2,317 | -2,514 | -2,362 | 2,150 | -2,113 | -534 | -11,316 |
基本每股稅後盈餘(元) | -0.56 | -0.79 | -0.55 | -0.27 | -0.41 | - | 0.65 | -2.75 | -1.03 | -3.00 |
稀釋每股稅後盈餘(元) | -0.56 | -0.80 | -0.57 | -0.24 | -0.41 | 1.55 | 1.41 | -2.75 | -1.03 | -2.95 |
基本平均股數(千股) | 8702.00 | 8718.00 | 8702.00 | 8702.00 | 6170.00 | - | 3308.00 | 518.00 | 518.00 | 1359.00 |
稀釋平均股數(千股) | 8702.00 | - | 8702.00 | 8702.00 | 6170.00 | - | 3766.00 | 518.00 | 518.00 | 1359.00 |
還原基本每股稅後盈餘(元) | -0.56 | -0.79 | -0.55 | -0.27 | -0.41 | - | 0.65 | -2.75 | -1.03 | -3.00 |
還原稀釋每股稅後盈餘(元) | -0.56 | -0.80 | -0.57 | -0.24 | -0.41 | 1.55 | 1.41 | -2.75 | -1.03 | -2.95 |
還原基本平均股數(千股) | 8,702 | 8,718 | 8,702 | 8,702 | 6,170 | - | 3,308 | 518 | 518 | 1,359 |
還原稀釋平均股數(千股) | 8,702 | - | 8,702 | 8,702 | 6,170 | - | 3,766 | 518 | 518 | 1,359 |
EBITDA(千元) | -5,146 | -7,089 | -5,238 | -2,655 | -2,514 | -2,362 | 2,150 | -2,118 | -534 | -11,525 |